Vibrent Health CEO Praduman “PJ” Jain, who also serves as principal investigator of the NIH All of Us Research Program’s Participant Technology Systems Center, joined Healthcare IT News Executive Editor Mike Miliard to talk about the All of Us program, why his company is working with NIH on the initiative, how to ensuring clinical trials represent a broader cross-section of society, and what recent FDA guidance on clinical trial diversity might accomplish.
Like what you hear? Subscribe to the podcast on, or !
The National Institutes of Health’s All of Us Research Program – where it is on its journey to building a cohort of 1 million participants
Vibrent Health and how it’s working on this initiative
FDA draft guidance from this past April, on enrolling more participants from underrepresented racial and ethnic populations in the U.S. into clinical trials
Research inclusion goals in the All of Us program
How diversity is defined, and why it’s broader than race and ethnicity
How technology and digital health tools can help boost clinical trial diversity
More about this episode:
Email the writer:
Healthcare IT News is a HIMSS publication.